Mobilisation of haemopoietic progenitors in CML: a second course of intensive chemotherapy does not improve Ph-negativity in stem cell harvests

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Bone Marrow Transplantation

• Publication date

  2000-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.bmt.1702420PMID 10849527
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factor.

  1999cited by this paper
• Mini-ICE regimen as mobilization therapy for chronic myelogenous leukaemia patients at diagnosis

  1999cited by this paper
• A clinical trial of retroviral-mediated transfer of a rev-responsive element decoy gene into CD34(+) cells from the bone marrow of human immunodeficiency virus-1-infected children.

  1999cited by this paper
• Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?

  1999cited by this paper
• Autografting with philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia.

  1999cited by this paper
• Comparative Analysis of Autografting in Chronic Myelogenous Leukemia: Effects of Priming Regimen and Marrow or Blood Origin of Stem Cells

  1998cited by this paper
• Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CML

  1998cited by this paper
• Effective mobilization of Philadelphia‐chromosome‐negative cells in chronic myelogenous leukaemia patients using a less intensive regimen

  1998cited by this paper
• Outcome of peripheral blood stem cell mobilization in advanced phases of CML is dependent on the type of chemotherapy applied

  1998cited by this paper
• Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and G-CSF

  1998cited by this paper
• Mobilization of Philadelphia‐negative peripheral blood progenitor cells with chemotherapy with rhuG‐CSF in chronic myelogenous leukaemia patients with a poor response to interferon‐alpha

  1998cited by this paper
• Collection of Philadelphia-negative peripheral blood progenitor cells in unselected patients with chronic granulocytic leukaemia

  1998cited by this paper
• Collection of Ph‐negative progenitor cells with granulocyte‐colony stimulating factor in patients with chronic myeloid leukaemia who respond to recombinant alpha‐interferon

  1998cited by this paper
• Bcl-2-independent Bcr–Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL

  1998cited by this paper
• Mobilization and transplantation of Philadelphia chromosome‐negative peripheral blood progenitor cells in patients with CML

  1998cited by this paper
• Comparative analysis of autografting in chronic myelogenous leukemia: effects of priming regimen and marrow or blood origin of stem cells.

  1998cited by this paper
• Autografting for chronic myeloid leukaemia.

  1997cited by this paper
• Mobilization of predominantly Philadelphia chromosome‐negative blood progenitors using cyclophosphamide and rHUG‐CSF in early chronic‐phase chronic myeloid leukaemia: correlation with Sokal prognostic index and haematological control

  1997cited by this paper
• Downregulation of Bcr-Abl in K562 cells restores susceptibility to apoptosis: Characterization of the apoptotic death

  1997cited by this paper
• Molecular analysis of hematopoietic colonies derived from chronic myeloid leukemia patients: interphase fluorescence in situ hybridization compared with RT-PCR

  1997cited by this paper
• 12 Autografting for chronic myeloid leukaemia

  1997cited by this paper
• Bcr – Abl-mediated resistance to apoptosis is independent of PI 3-kinase activity

  1997cited by this paper
• Granulocyte colony‐stimulating factor given in addition to interferon‐α to mobilize peripheral blood stem cells for autologous transplantation in chronic myeloid leukaemia

  1997cited by this paper
• Treatment of chronic myeloid leukaemia in first chronic phase with idarubicin and cytarabine: mobilization of Philadelphia‐negative peripheral blood stem cells

  1997cited by this paper
• Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia.

  1997cited by this paper
• The repression of apoptosis by activated abl oncogenes in chronic myelogenous leukaemia.

  1996cited by this paper
• Cyclophosphamide/GM-CSF priming in autotransplant therapy for CML.

  1996cited by this paper
• Autografting in chronic myeloid leukemia: an overview.

  1996cited by this paper
• Intensive treatment in order to minimize the Ph-positive clone in CML. Danish-Swedish CML Group.

  1996cited by this paper
• MOBILIZATION OF PHILADELPHIA‐NEGATIVE PERIPHERAL BLOOD MONONUCLEAR CELLS IN CHRONIC MYELOID LEUKAEMIA USING HYDROXYUREA AND G‐CSF (FILGRASTIM)

  1996cited by this paper
• Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia.

  1996cited by this paper
• Preliminary results of stem cell mobilization in chronic myeloid leukemia with a moderate intensity chemotherapy regimen and G-CSF or G-CSF plus IL-3.

  1996cited by this paper
• Iron overload and liver dysfunction after allogeneic or autologous bone marrow transplantation.

  1996cited by this paper
• Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cells.

  1995cited by this paper
• Regulation of the Fas Apoptotic Cell Death Pathway by Abl (*)

  1995cited by this paper
• Collection of peripheral-blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive-dose chemotherapy.

  1995cited by this paper
• UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia.

  1995cited by this paper
• BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents.

  1995cited by this paper
• UK Medical Research Council randomised, multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response

  1995cited by this paper
• Autografting in chronic myeloidleukaemia

  1994cited by this paper
• BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death.

  1994cited by this paper
• Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT.

  1994cited by this paper
• Autografting for patients with CML in chronic phase: an update

  1994cited by this paper
• Autografting in chronic myeloid leukaemia.

  1994cited by this paper
• Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups.

  1994cited by this paper
• Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia.

  1994cited by this paper
• Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group.

  1994cited by this paper
• Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia.

  1994cited by this paper
• BCR-ABL Maintains Resistance of Chronic Myelogenous Leukemia Cells to Apoptotic Cell Death

  1994cited by this paper
• Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia.

  1993cited by this paper
• Autologous blood stem cell transplantation for chronic granulocytic leukaemia in transformation: a report of 47 cases

  1991cited by this paper
• Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome.

  1990cited by this paper
• Primary human myeloid leukemia cells: comparative responsiveness to proliferative stimulation by GM-CSF or G-CSF and membrane expression of CSF receptors.

  1987cited by this paper
• Chemotherapy and autografting for chronic granulocytic leukaemia in transformation: probable prolongation of survival for some patients

  1984cited by this paper
• Long-term marrow culture reveals chromosomally normal hematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.

  1983cited by this paper
• Philadelphia chromosome (Ph1)-negative chronic myelogenous leukemia (CML): a clonal disease with origin in a multipotent stem cell.

  1980cited by this paper

• Chronic myeloid leukemia in the Netherlands: a population‐based study on incidence, treatment, and survival in 3585 patients from 1989 to 2012

  2016cites this paper
• Hematopoietic Stem Cell Transplantation for Chronic Myeloid Leukemia

  2016cites this paper
• Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era

  2014cites this paper
• High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study

  2006influential citation
• Identification of genes potentially involved in disease transformation of CML

  2005cites this paper
• Autologous hematopoietic cell transplantation for chronic myelogenous leukemia.

  2004cites this paper
• Recent publications in hematological oncology.

  2001cites this paper